Cargando…
High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research
The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda startin...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931324/ https://www.ncbi.nlm.nih.gov/pubmed/24499316 http://dx.doi.org/10.1186/1472-6882-14-46 |
_version_ | 1782304642932146176 |
---|---|
author | Fischer, Felix H Lewith, George Witt, Claudia M Linde, Klaus von Ammon, Klaus Cardini, Francesco Falkenberg, Torkel Fønnebø, Vinjar Johannessen, Helle Reiter, Bettina Uehleke, Bernhard Weidenhammer, Wolfgang Brinkhaus, Benno |
author_facet | Fischer, Felix H Lewith, George Witt, Claudia M Linde, Klaus von Ammon, Klaus Cardini, Francesco Falkenberg, Torkel Fønnebø, Vinjar Johannessen, Helle Reiter, Bettina Uehleke, Bernhard Weidenhammer, Wolfgang Brinkhaus, Benno |
author_sort | Fischer, Felix H |
collection | PubMed |
description | The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens’ needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public’s health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges. |
format | Online Article Text |
id | pubmed-3931324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39313242014-02-22 High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research Fischer, Felix H Lewith, George Witt, Claudia M Linde, Klaus von Ammon, Klaus Cardini, Francesco Falkenberg, Torkel Fønnebø, Vinjar Johannessen, Helle Reiter, Bettina Uehleke, Bernhard Weidenhammer, Wolfgang Brinkhaus, Benno BMC Complement Altern Med Correspondence The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens’ needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public’s health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges. BioMed Central 2014-02-06 /pmc/articles/PMC3931324/ /pubmed/24499316 http://dx.doi.org/10.1186/1472-6882-14-46 Text en Copyright © 2014 Fischer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Correspondence Fischer, Felix H Lewith, George Witt, Claudia M Linde, Klaus von Ammon, Klaus Cardini, Francesco Falkenberg, Torkel Fønnebø, Vinjar Johannessen, Helle Reiter, Bettina Uehleke, Bernhard Weidenhammer, Wolfgang Brinkhaus, Benno High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title | High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title_full | High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title_fullStr | High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title_full_unstemmed | High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title_short | High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
title_sort | high prevalence but limited evidence in complementary and alternative medicine: guidelines for future research |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931324/ https://www.ncbi.nlm.nih.gov/pubmed/24499316 http://dx.doi.org/10.1186/1472-6882-14-46 |
work_keys_str_mv | AT fischerfelixh highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT lewithgeorge highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT wittclaudiam highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT lindeklaus highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT vonammonklaus highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT cardinifrancesco highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT falkenbergtorkel highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT fønnebøvinjar highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT johannessenhelle highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT reiterbettina highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT uehlekebernhard highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT weidenhammerwolfgang highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch AT brinkhausbenno highprevalencebutlimitedevidenceincomplementaryandalternativemedicineguidelinesforfutureresearch |